SENEB vs COLL

Comparison between Seneca Foods Corp - Class B (SENEB, Company) and Collegium Pharmaceutical Inc (COLL, Company).

SENEB is from the Consumer Defensive sector, while COLL is from the Healthcare sector.

5-Year PerformanceSENEB has outperformed COLL, delivering a return of +25.6% compared to +7.9%

SENEB vs COLL - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	SENEB(COMPANY)	COLL(COMPANY)
Market Cap	$1.08B	$1.09B
Max Drawdown	53.42%	73.59%
Sharpe Ratio	1.57	0.48
5Y Beta	-0.02	0.50
Industry	Packaged Foods	Drug Manufacturers - Specialty & Generic
P/E Ratio	10.44	36.80
Forward P/E	48.08	4.50
PEG Ratio	0.64	0.00
5Y EPS CAGR	73.51%	-5.45%
Debt to Equity	40.74%	0.00%
Free Cash Flow Yield	15.55%	30.34%
P/S Ratio	0.65	1.36
P/B Ratio	1.42	3.48

Market Cap

SENEB

$1.08B

Winner

COLL

$1.09B

Max Drawdown

Winner

SENEB

53.42%

COLL

73.59%

Sharpe Ratio

Winner

SENEB

1.57

COLL

0.48

5Y Beta

Winner

SENEB

-0.02

COLL

0.50

Industry

SENEB

Packaged Foods

COLL

Drug Manufacturers - Specialty & Generic

P/E Ratio

Winner

SENEB

10.44

COLL

36.80

Forward P/E

SENEB

48.08

Winner

COLL

4.50

PEG Ratio

SENEB

0.64

Winner

COLL

0.00

5Y EPS CAGR

Winner

SENEB

73.51%

COLL

-5.45%

Debt to Equity

SENEB

40.74%

Winner

COLL

0.00%

Free Cash Flow Yield

SENEB

15.55%

Winner

COLL

30.34%

P/S Ratio

Winner

SENEB

0.65

COLL

1.36

P/B Ratio

Winner

SENEB

1.42

COLL

3.48

SENEB vs COLL - Historical Returns

Returns include dividend reinvestment.

Period	SENEB	COLL
1 month	+11.24%	+1.61%
3 months	+13.86%	-0.33%
6 months	+38.43%	-29.13%
1 year	+71.61%	+15.86%
5 years(CAGR)	+25.57%	+7.91%
10 years(CAGR)	+15.40%	+9.72%
Max(CAGR)	+10.26%	+9.75%

Winner

SENEB

+11.24%

COLL

+1.61%

Winner

SENEB

+13.86%

COLL

-0.33%

Winner

SENEB

+38.43%

COLL

-29.13%

Winner

SENEB

+71.61%

COLL

+15.86%

5Y(CAGR)

Winner

SENEB

+25.57%

COLL

+7.91%

10Y(CAGR)

Winner

SENEB

+15.40%

COLL

+9.72%

Max(CAGR)

Winner

SENEB

+10.26%

COLL

+9.75%

SENEB vs COLL - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	SENEB	COLL
2026	+44.67%	-23.96%
2025	+37.97%	+61.72%
2024	+53.72%	-8.26%
2023	-14.65%	+30.53%
2022	+26.13%	+21.53%
2021	+19.24%	-5.94%
2020	-3.66%	-7.27%
2019	+39.12%	+15.62%
2018	-13.32%	-8.18%
2017	-19.05%	+17.73%
2016	+31.25%	-40.64%
2015	+0.25%	+123.76%
2014	+1.23%	N/A
2013	+0.19%	N/A
2012	+15.17%	N/A
2011	-4.30%	N/A
2010	+14.73%	N/A
2009	+5.24%	N/A
2008	+0.00%	N/A
2007	+6.95%	N/A
2006	+26.60%	N/A
2005	+6.90%	N/A
2004	-17.04%	N/A
2003	+36.14%	N/A
2002	+15.43%	N/A
2001	-0.93%	N/A
2000	+22.87%	N/A
1999	-2.13%	N/A

SENEB vs COLL Drawdown Comparison

The maximum drawdown for SENEB was -53.42%, occurring on Jul 3, 2023. Recovery took 496 trading sessions.

The maximum drawdown for COLL was -73.59%, occurring on May 8, 2017. Recovery took 550 trading sessions.

The current SENEB drawdown is -6.30%. The current COLL drawdown is -30.54%.

Rank	SENEB	COLL
#1	-53.42% Nov 28, 2022 - Nov 18, 2024	-73.59% Dec 30, 2015 - Mar 8, 2018
#2	-48.33% Jan 23, 2017 - Aug 27, 2020	-65.22% Mar 8, 2018 - Feb 1, 2023
#3	-46.85% Jun 14, 2006 - Jun 26, 2009	-41.07% Oct 4, 2024 - Nov 7, 2025
#4	-42.12% Jun 30, 2009 - Mar 11, 2013	-38.84% Dec 26, 2025 - Jun 2, 2026
#5	-29.03% Sep 23, 2016 - Jan 23, 2017	-35.05% Jul 31, 2015 - Sep 16, 2015
#6	-28.39% Sep 1, 2020 - Feb 9, 2021	-33.28% Sep 18, 2015 - Dec 14, 2015
#7	-28.28% Dec 9, 2003 - May 19, 2006	-29.52% Feb 2, 2023 - Dec 18, 2023
#8	-27.28% Mar 9, 2021 - Aug 4, 2022	-23.34% Mar 27, 2024 - Oct 4, 2024
#9	-24.88% Feb 19, 2015 - Jul 12, 2016	-14.67% Jun 11, 2015 - Jul 31, 2015
#10	-24.44% Jul 18, 2013 - Feb 19, 2015	-12.81% Dec 17, 2015 - Dec 30, 2015
#11	-23.98% Aug 4, 2022 - Nov 8, 2022	-7.18% Nov 12, 2025 - Dec 2, 2025
#12	-20.32% Apr 10, 2026 - Jun 12, 2026	-6.45% Feb 15, 2024 - Feb 23, 2024
#13	-17.90% Aug 9, 2000 - Feb 8, 2002	-6.29% May 22, 2015 - Jun 3, 2015
#14	-16.10% May 20, 2013 - Jul 17, 2013	-6.26% Jan 3, 2024 - Jan 29, 2024
#15	-15.87% Apr 26, 2002 - Dec 23, 2002	-5.02% Jan 29, 2024 - Feb 15, 2024